Effects of Elexacaftor Tezacaftor Ivacaftor on sinonasal imaging in children with cystic fibrosis
This study highlights ETI's efficacy in improving sinonasal involvement in children aged 6 to 12 with CF. This is in line with the observations of clinical improvement, and presents an alternative to sinus surgery, thus potentially leading to a reduction in surgical interventions.
Institutions
- Hôpital Femme Mère Enfant (FR)
- Hospices Civils de Lyon (FR)
Publication Details
- Journal
- Rhinology Journal
- Published
- 2025-01-09
- DOI
- https://doi.org/10.4193/rhin24.533
- Primary Topic
- Geochemistry and Geologic Mapping
- Type
- article
- Field-Weighted Citation Impact
- 0.00